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gene names are italicized, the protein names are written in regular letters. Human





















suggested genetic heterogeneity in PLOSL, and encouraged us to search for other
PLOSLgenes.SinceDAP12encodesacell-surfacereceptorelementthatinteractswith
many different proteins depending on the cell type, we used a genetic approach to
search for genes involved in PLOSL. By analyzing families not linked to DAP12 for
segregation of marker haplotypes flanking genes coding for the DAP12-associated
polypeptides, we identified a single chromosomal region that showed a complete
cosegregation with PLOSL. Sequencing of the regional candidate genes revealed
mutations in TREM2. On the cell surface TREM2 is expressed as a complex with
DAP12andmediatesthedifferentiationofdendriticcells.

Since then we have detected mutations in all PLOSL patients in either DAP12 or
TREM2. A total of 73% (n=37) of the patients carry amutation in DAP12 and 27%








osseous symptoms and signs before the onset of neurological manifestations.
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Therefore, radiographic examination of ankles or wrists should be considered in all
casesofapreseniledementiaofunknownorigintoensurethecorrectdiagnosis.

Inorder to initiate thecharacterizationof thepathogenesisofPLOSL,we testedour
hypothesis that osteoclasts, the bone remodeling cells, are responsible for the
generationofthebonelesions.Westudiedthedifferentiationofosteoclastsinpatients
with loss-of-function mutations in DAP12 or TREM2, and found that loss of





However, DAP12- or TREM2-deficient PLOSL patients do not seem to present with






andneuropathological courseofPLOSLwas characterized in detail by performinga
long-termfollow-upanalysisofaseriesofPLOSLpatients.Finally,DAP12andTREM2




































understood. Repetitive elements are likely to account for over 50% of the genome.
Repetitive elements can be divided into 5 main categories: 1) transposon-derived
repeats (such as Alu repeats), comprising approximately 45% of the genome; 2)
processedpseudogenes(0.5%ofthegenome),thatarenon-functionalgenesthathave
been moved from their original location through an RNA intermediate; 3) simple
sequence repeats that are typically repetitions of short n-mers (mono-, di- or
trinucleotiderepeats);4)segmentalduplicationsofblocksofaround10-300kbthathave
been copied from one region of the genome to another region; and 5) blocks of
tandemly repeated sequences, such as at centromeres and telomeres (Prak and
Kazazian2000;Landeretal.2001;Scriveretal.2001;Collinsetal.2003).Attheends
of each chromosome there are telomeres, which stabilize the chromosome, prevent
fusion with other DNA, and enable DNA replication without loss of chromosomal
material.








established to enable a better understanding of the human genome and to provide
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primary goal of theHGP was achieved in April 2003when the International Human
Genome Sequencing Consortium completed the sequencing of the human genome




us to understand what makes human unique among other species. The size of the
genomedoesnotcorrelatewellwiththecomplexityofanorganism.Forexample,the














of differences compared to the DNA of another individual, except in the case of
monozygoustwins.TheDNAdifferencescanbedividedintofourmaincategories:a)
those with no phenotypic effect (e.g. most short tandem repeat polymorphisms), b)




pairs in thehumangenomeareestimated tobepolymorphic.Mosthumansequence
variation is attributable to single-nucleotide polymorphisms (SNP), with the rest
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attributable to tandemly repeated sequences, insertions or deletions of one ormore
nucleotides,andrearrangements.SNPsareestimatedtooccurevery1000-2000bases
whentwohumanchromosomesarecompared.Some4%ofSNPsfallwithincodingand




Model organisms are key informational tools for understanding the contents of the
human genome, and important experimental tools because these genomes help
researcherscharacterizeand interpret thehumangenome.Todate, thegenomesof
numerous model organisms have been sequenced. Complete genomes have been
obtained from nine eukaryotes including two widely used animal model organisms,
namelyfruitfly(Drosophilamelanogaster)andworm(Caenorhabditiselegans),aswell





The mouse (Mus musculus) is likely to be the most important model organism. In




consists of 20 chromosomes. Comparative analysis has revealed that the mouse
genomeisabout14%smallerthanthehumangenome(2.5Gbcomparedto2.9Gb).At
thenucleotide level,approximately40%of themousegenomecanbealigned to the
human genome. Interestingly, the mouse and human genomes contain the same
number of protein-coding genes. The proportion of mouse genes with a single




Thecontributionofgenetic factors in theetiologyofdisordersvaries fromcompletely
genetically determined (e.g. phenylketonuria) to completely environmentally induced
(e.g. accidents). The role of genetic factors in diseases can be divided into five
categories: a) Mendelian (monogenic) disorders, b) chromosomal aberrations, c)
 14 
mitochondrial disorders, d) multifactorial disorders, and e) somatic cell genetic
disorders.

For simplicity, genetic disorders are classically divided into single-gene disorders or
complexdiseasetraits.Inreality,thereisacomplexcontinuuminvolvinga)thenumber
of loci, b) the relative influence of each allele, c) nongenetic factors, such as





calledmonogenic orMendeliandiseases. InMarch2003 theHumanGeneMutation
Database(HGMD)contained33252mutationsfoundin1338genes(Table1).Thetrue




















Monogenic diseases become manifest when the patient carries one or two disease
alleles, depending on whether the mode of inheritance is autosomal recessive,
autosomaldominant,orX-linked.Environmentalfactorshavelittleornoinfluenceonthe





























some exceptions: unstable mutations, uniparental disomy and imprinted genes.
UnstablemutationsinvolvetheexpandingtripletdiseasessuchasHuntingtondisease
and spinocerebellar ataxias, in which the disease phenotype worsens over the
generations (anticipation) due to increasing number of repeats. Uniparental disomy
existswhenanindividualinheritstwocopiesofpartorallofachromosomefromone
parent.Thesignificanceofuniparentaldisomyismostlycausedbygeneticimprinting,in






thephenotype isexpressedonlywhenthemutatedallele is inherited fromthe father
(Scriveretal.2001).

The clinical risk forX-linked disorders are different for the two sexes. Inmales, the




The mitochondrial genome is inherited from the mother. Therefore, males do not




Multifactorial or complex diseases are caused by interactions of multiple genes and
environmental factors. These disorders become manifest only when an individual
inherits a certain combination of disease-predisposing alleles, and triggering
environmental influences are present. Many of the common chronic illnesses of





There are several strategies that can be utilized to identify the causative genes for
humandiseases.Thestrategiescanbedivided into fourmaincategories:  functional
cloning, thecandidategeneapproach,positionalcloningand thepositionalcandidate
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themutated protein and gene. Therefore, the possibilities to utilize this strategy are






or supposed function, are directly analyzed formutations or linkage in families. The







the genome; no knowledgeof its function is required.This strategy depends on the
analysisofaffectedfamilieswithgeneticmappingtofindachromosomalregionlinkedto
thedisease.Having localized thedefectivegene inachromosomal locus, thecritical
region is further restrictedwith linkagedisequilibriumandsharedhaplotypeanalyses.
With increasing knowledge of the human genome, the principal disease gene
identificationmethodnowadays isamixtureofpositionalcloningandcandidategene
methods called the positional candidate gene approach.  After assignment of the
diseaselocus,theregionalcandidategenesareselectedandanalyzedbasedontheir
known function (Scriver et al. 2001). When sufficient knowledge of the molecular
mechanismsof thediseaseareavailable thismethodmaybeveryefficientand fast.




















Finnish gene pool is thought to originate from later small founder populationswhich
immigratedfromthesouthapproximately2000yearsago.However,sincethereisno
unequivocalevidence for twodistinct immigrationwaves, it isactuallymoreprobable














chromosome and mitochondrial DNA show that Finns differ from other European





thecreationofsmall immigrantgroups fromthemainpopulationallowedthe founder
effect (i.e., amutation enriched in a specific population due to the presence of that























theenrichmentof someMendeliandiseases inFinland, creating theFinnishdisease
heritage.On the other hand, some other disorders relatively common in otherwhite





Theancestors of thepatients originate from the late settlement region in half of the
cases.InsixdiseasesoftheFinnishdiseaseheritage,thebirthplacesoftheancestors
have been distributed relatively evenly throughout the country, however, the late
settlement area is overrepresented (AGU, Batten disease, cartilage-hair hypoplasia,










Figure 1. The first founder populations

















































































































































is composed of the first letters of the characteristic pathologic findings: Polycystic
LipomembranousOsteodysplasiawithSclerosingLeukoencephalopathy.PLOSLisalso
































fractures in the bones of the extremities afterminimal trauma typically occur shortly
Figure2.Regionalclusteringofthebirthplaces
ofgrandparentsofPLOSLpatients(dots)inthe
eastern Finland (Kuopio district) indicates that






distal endof the long tubular bones.The fracturesusually healwell. 3)At theearly










































whole family series. Using this approach, the PLOSL locus was assigned to chr.
19q13.1.Usinghaplotypeanalysis,thecriticalPLOSLregionwasrestrictedto153kb















years to reachabout 30%at 80 years.Themost commoncauses for dementia are
Alzheimer'sdisease(AD),vasculardementiaanddementiawithLewybodies.InEurope
and North America, AD is estimated to be the most common cause of dementia,
whereasvasculardementiahasbeenreportedtobemoreprevalentthanADinseveral





made in thepastdecade.However, thegeneticbackgroundofmostof thecommon


































Alzheimer's disease is characterized by slowly progressive adult-onset dementia
associatedwithcerebralatrophymostprominent in the frontal, temporalandparietal
corticalareas.Thetypicalclinicaldurationofthediseaseiseighttotenyears,witha
rangeofone to25years.ThehistopathologicalhallmarksofADareneuriticplaques



















familial AD are autosomally dominantly inherited and caused by mutations in genes
coding for amyloid precursor protein (APP; AD type 1) (Cummings et al. 1998),
presenilin1(PSEN1;AD3)(Sherringtonetal.1995;Crooketal.1998),orpresenilin2










Cerebral autosomal dominant arteriopathy with subcortical infarcts and
leukoencephalopathy (CADASIL) is a microangiopathy primarily affecting the brain.
Ischemicattacks(TIAsorstroke)atthemeanageofonsetof45yearsarethemost
frequent findings manifesting in ~85% of the patients. Cognitive decline, including
dementia,begins todevelopat thesame time.Byage65, two-thirdsof thepatients
sufferfromdementia.MigrainewithauraisamongthefirstsymptomsofCADASILand










is typically 40-60 years. The patients present with slowly progressive behavioral
changes,suchasdisinhibitionandlossofinitiativeinadditiontolanguagedisturbances
and extrapyramidal signs. Some patients present with rigidity, bradykinesia,
supranuclear palsy, and saccadic eye movement disorders. The disease progresses
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cerebralhemorrhagewithamyloidosis (HCHWA),Finnish,Dutchand Icelandic types.
The Finnish type HCHWA (gelsolin-related amyloidosis) is an autosomal dominant
disorder and is causedbymutations in thegelsolin gene (GSN) (Levy et al. 1990b;
Paunio et al. 1992). Gelsolin-related amyloidosis is characterized by facial palsy,
peripheral neuropathy and corneal lattice dystrophy. Some patients present with
cognitivedecline(Kiuruetal.1999).TheDutchtype(-D)ofHCHWAischaracterizedby





cystatin C  (CST3) (Levy et al. 1989). HCHWA-I usually manifests with cerebral







in that they can be at the same time inherited and infectious. The prion protein is
encodedbythePRNPgene.Thepathogenicityofabnormalprionpolypeptides(PrPSc)
is mediated by their abnormal conformation. PrPSc molecules are able to cause a
conversion of normal isoform of the prion protein (PrPC) to pathogenicPrPSc that is
insoluble and tends to aggregate. Six different forms of human prion diseases have
been described, including Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-
Scheinker(GSS),fatalfamilialinsomnia(FFI),newvariantCJD,kuru,andatypicalprion
disease.AutosomaldominantmutationsinPRNPgeneeitherresultinCJD,FFI,GSS,
phenotype intermediate between CJD and GSS, or a phenotype lacking distinctive







phenotype depends on the genotype at a different codon (position 129). Patients
carrying the D178N mutation and valine at position 129 present with typical CJD,
whereaspatientswithD178Nandmethionineatposition129developFFI.Thetypical
symptoms of CJD are progressive dementia, gait disturbance and behavioral
disturbanceswhereasthesymptomsofFFI,e.g.completeinsomnia,dementia,rigidity,
andmutism,markedlydifferfromCJD.Similarly,theneuropathologicmanifestationsof





The typical symptomsofHD includechorea,dementia,andbehavioral disturbances.














osteomalacia), and infectious diseases (e.g. osteomyelitis) as well as traumas
(fractures) and tumors (Kumar et al. 1997). Although the skeleton houses the bone





disorders can be classified into two major categories: impaired development and
defectivemaintenanceofbone.Achondroplasiaisadisorderofbonedevelopmentand
themostcommonhumandiseasethatresultsindwarfism.Thedisorderiscausedby
autosomal dominantmutations in gene coding for fibroblast growth factor receptor 3
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characterized by the occurrence of multiple spontaneous fractures due to abnormal




Osteoporosis is an extremely common disease of the elderly. The World Health
Organization defines osteoporosis as bone mineral density in the spine over 2.5
standard deviations below the "young normal" mean value. Osteoporotic bones are
brittleandpronetopathologicalfractures.Thecomplicationsofosteoporosis(e.g.hip
fractures) are a significant cause of death in Western countries. The pathogenic
mechanism of osteoporosis is a long-term imbalance between bone formation and
resorption that results in a decrease in total bone mass and density.Metabolic and
genetic,inadditiontonutritionalandseveralotherlifestylefactorstogetherhavetheir

























This study was undertaken when the autosomal recessive mode of inheritance of










































For the characterizationof the natural courseofPLOSL, clinical, neurophysiological,
andimagingdataoneightpatientswereavailable(III).Fivepatientswereexaminedat








in theseparatesection),Genotator (Harris1997),Genscan (BurgeandKarlin1997),
Grail(Xuetal.1994)andMZEF(Zhang1997).







Northern-blot analysis of human cells and tissues were performed using [32P]-
radiolabeled human DAP12 and TREM2 cDNAs as probes. Poly(A)+ RNA from the
FinnishPLOSLandcontrollymphoblastcelllinesfornorthern-blotanalysiswasisolated
usingaFastTrack2.0mRNAisolationkit(Invitrogen).Poly(A)+RNAwasseparatedby
electrophoresis and transferred to a nylon membrane as previously described
(Sambrook1989).Humanmultiple-tissuenorthernblots(Clontech)andamultiple-tissue
mRNA expression array (Clontech) were hybridized according to the manufacturer's
instructions.Theprobes,correspondingtothetranscribedregionofDAP12andTREM2,
weregeneratedbyPCR fromcDNAclones (GenBankaccessionnumbersare found








for 1, 3, 7 and 21 days as described below. Total RNA was isolated using TRIzol
reagent (GibcoBRL). Quantitative RT-PCR experiments were performed using a
LightCycler PCR machine (Roche, Molecular Biochemicals) as described previously
(Palonevaetal.2002;Konttinenetal.2001).SerialdilutionsofhumanDAP12,TREM2,
TRAP,andCALCR)cDNAclonedinaplasmidvectorwereusedtodeterminethecopy











PBMC were tested for cytotoxicity against  K562 erythroleukaemia cells. Before the






cent cytotoxicity (Cx) was  calculated using the formula % Cx=(test release–







cells were washed with PBS and  lysed withNP40 lysis buffer. The  proteinswere
immunoprecipitated from lysates with the  anti-human DAP12 monoclonal antibody
DX37 (a mouse IgG1  generated by immunizing Balb/c mouse with a polypeptide
correspondingtothecytoplasmicdomainofhumanDAP12).Immunoprecipitateswere
collected with protein A/G–Sepharose  (Pharmacia Biotech) and washed with NP40
lysis buffer. The beads were boiled in sample buffer (Laemmli), and aliquots were
separatedon4–20% gradientSDS–PAGEgels (Readygel,BioRad) forwestern-blot
analysis using the same monoclonal antibody. DAP12 was visualized using HRP
conjugatedanti-mouseIg(PharmaciaBiotech)andECL(SuperSignal,PierceChemical
Company).DAP10lysateswereimmunoprecipitatedfromlymphoblastsobtainedfrom
the Finnish PLOSL patient and a control subject  using an affinity-purified (with the


















eosin, van Gieson, Luxol Fast Blue-cresyl violet, modified Bielschowsky silver stain,
periodic acid-Schiff (PAS), elastin, and Congo red methods, according to standard
protocols.Thebonesweredecalcifiedbeforecutting them intosections,and stained
withH&EandforTRAP.

Immunostaining was performed by using the avidin-biotin complex (ABC) technique
(Vectastain ABC-kit, Vector Laboratories, Burlingame, CA). Monoclonal antibodies
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against amyloid beta-protein (clone 4G8, Senetek, MD Heights, MO; Clone 6F3D,
Novocastra Laboratories, Newcastle, UK), α-synuclein (clone LB509, Zymed
Laboratories, South Francisco, CA), phosphorylated tau-protein (Clone AT8,




deparaffinized sections at recommended dilutions after appropriate pretreatments.





cells over Ficoll-Paque (Amersham Pharmacia Biotech, Uppsala, Sweden). PBS






















Staining for TRAP was performed using a TRAP staining kit (Sigma-Aldrich). The
cytoskeletal actinwas stainedusingAlexaFluor 633phalloidin reagent according to
instructions provided by the manufacturer (Molecular Probes). The nuclei were
visualized using DAPI reagent (Sigma-Aldrich). The staining for cathepsin K was






(AD000833), R31158 (AF038458), R31874  (AD000823) and R28125 (AD000827).
DAP12genomicsequence,AF019563;DAP12cDNAsequence,N41026,AF019562
andAA481924; DAP10genomicsequence,AF072845;APLP1genomic  sequence,





























chr. 19q13.1 using genome-wide linkage, linkage disequilibrium and haplotype












these methods we identified three previously unknown putative transcripts or EST


















E/P, EST contig or predicted transcript. The polymorphic markers restricting the region are
indicated as their D-names. StyI, restriction enzyme polymorphism. The arrows indicate the
orientation (cen-tel or tel-cen) of the genes. E/P 1: FILTRIN, E/P 2: TA-NFKBH. The scale
































positional cloning approach. The only promising regional  candidate gene was the
amyloid-precursor -like protein geneAPLP1 because of its homology to the amyloid
precursor protein (APP) gene that is mutated in patients with familial Alzheimer’s
disease type I (Lendon et al. 1997). Sequence analysis of the genomic DNA
(Pekkarinenetal.1998b)andnorthernanalysisofthesteadystatemRNAdidnotreveal





























one family)  (I), Norway (PLOSLFin,
 one family) (I) (Tranebjaerg et al. 2000), Japan
(PLOSLJpn,
 141delG, one family) (I), Portugal (145G>C) (Baeta et al. 2002), the UK















translation termination codonsare separated by only 408bp.ThePLOSLFin deletion
doesnotincludetheknownsequenceofDAP10,butgiventheproximityofthegenes,
we explored the possibility that the deletion affects transcript levels ofDAP10. Both
patient and control lymphoblast lines yielded abundant DAP10 transcripts; no





SinceDAP12 isanactivatingNKcell receptor,we investigatedNKcell functionand
number in Finnish PLOSL patients with loss-of-function mutations in DAP12.
Immunophenotyping of PBMCs from six Finnish PLOSL patients revealed that the
frequency of NK cells (CD3-CD56+) and CD56+ T cells (CD3+CD56+) were within
normallimits.Moreover,therewerenoabnormalitiesinthenumberorfrequencyofT
lymphocyte subpopulations (CD3+CD4+, CD3+CD8+). Furthermore, we detected no














genetic strategy to identify genes mutated in PLOSL patients with no mutations in
DAP12. We initially analyzed two informative families (Norwegian and Swedish)
showing exclusion of linkage to the PLOSL locus on chromosome 19q13.1, for
segregation of the marker haplotypes flanking genes that encode the polypeptides
interacting with human DAP12. These genes included those for human DAP12-
associated receptors SIRPB1 (chromosome 20p13) (Dietrich et al. 2000), TREM1
(chromosome 6p21.2), TREM2 (chromosome 6p21.2) (Bouchon et al. 2000), NKp44
(chromosome 6p22.1) (Vitale et al. 1998), MDL1 (chromosome 7q33) (Bakker et al.
1999), CD94 (chromosome 12p13.3), NKG2C (chromosome 12p13.1) (Lanier et al.
1998a) andKIR2DS2 (chromosome19q13.4) (Lanier et al. 1998b). Furthermore,we





showing complete cosegregation with PLOSL was on chr. 6p21 encompassing
approximately a 10 cM DNA region. This region contains genes coding for the


































Swedish family had a homozygous nonsense mutation at position 233 (233G>A),






DAP12 mutations (Table 6). Families with mutations in TREM2 are from Germany
(40G>T)(IV),Belgium(C97>T)(unpublished),Bolivia(132G>A)(II),Sweden(233G>A)















Brazil Del8kb Ex1-4 1
Japan 2T>C/Met1Thra Ex1 2
Japan 141delG/TPb Ex3 4
Portugal 145G>C/Gly49Arg Ex3 2
Scotland 154ins42bp Ex3 1
TREM2
Germany 40G>T/Glu14Stp Ex1 1
Belgium C97>T/Gln33Stp Ex2 2
Bolivia 132G>A/Trp44Stp Ex2 1
Sweden 233G>A/Trp78Stp Ex2 2
France(Turkey) 267delG/TP Ex2 1
Germany 313delG/TP Ex2 1
SriLanka 377T>G/Val126Gly Ex2 1
USA(Slovakia) 401A>G/Asp134Gly Ex3 1
Italy 482+2T>C/SP Int3 2










role forDAP12 inhumans.However, thestrongeststeady-stateDAP12mRNAsignal





















































































putamen  trachea  

Figure 5. a. spleen, b.
lymph node, c. thymus, d.
leukocytes, e. bone
marrow, f. fetal liver, g.
cerebellum, h. cerebral
cortex, i.medulla, j. spinal
cord, k. occipital pole, l.








DAP12 and TREM2 mutations, we compared the disease manifestations with each
other.Remarkably,wedidnotobservedifferencesintheclinicalsymptomsorsignsin
these two patient groups (Table 7). Thus, PLOSL is an interesting example of how
mutationsindifferentcomponentsofareceptorsignalingcomplexresultsinanidentical


































 TREM2  DAP12
Bones(3rddecade)   
Skeletalpain +  +
Bonelesionsorfractures +  +
CNS(4-5thdecades)   
Frontallobesyndromea +  +




Convulsions +  +
Primitivereflexes +  +
DiffuseslowingintheEEG +  +
Brainatrophy +  +






The first symptoms of PLOSL appeared in early adulthood. In their early 20s, four
patientshadhadpainand tenderness in theiranklesand feetafterstrainoraminor
accident.Thefirstfracturesoccurredatthemeanageof27years(range,18–33years),
mostcommonlyinthebonesoftheextremities.Radiographsshowedtrabecularlossin









social problems: divorces, unemployment, financial troubles, and suicide attempts.
Subsequently, the full-blown picture of the frontal lobe syndrome appeared in all
patients:lossofjudgment,euphoria,disinhibition,disturbanceofconcentration,aswell
as lack of insight and libido. Progressive signs of upper motor neuron involvement
(spasticity,Babinski’ssign)werenoticedatthesameageasthechangeofpersonality









Other disturbances of higher cortical functions, such as motor aphasia, agraphia,
acalculia, and apraxia, appeared only at the last stage of the disease. A very
conspicuous feature was postural dyspraxia. The patients walked or sat in peculiar
skewedpostures,forexample,withtheupperpartofthebodytiltedlaterallyupto20
degrees.Finally, thepatients lost theirability towalkat themeanageof42.5years
(range,34–47years).Atthefinalstage,thepatientslaywithoutanyactivemovementin
















MR images. This finding was probably caused by calcifications. The heads of the
caudatenucleiweresmallonMRI,andthebicaudateratioswereabnormallyhighfor










ratio was abnormal even at the first examination. Only in one patient with CNS
symptomsdidthewhitematter looknormal.Thebasalgangliacalcificationscouldbe




At theearlystageof thedisease, theEEGswerenormal.Patientswithmoderate to
severementalsymptomsshowedaccentuationofthethetaanddeltaactivities.Initially,






Theneuropathological findingswere similar in all patientswhounderwent autopsies.
Thebrainweights(1170,1170,and910g)weremarkedlybelownormal,andtherewas






























the deeper cortical laminae showed rounded contours, marginalization of the Nissl
granules, and eccentric nuclei, i.e., features of chromatolysis. Apart from a few
neurofibrillary tangles and neuropil threads in the entorhinal cortex, no other
intraneuronalorglialpathologicinclusions,immunoreactiveforphosphorylatedtau,α-
synuclein, or ubiquitin, were present. There were no cortical or nigral Lewy bodies,
Figure6.a)Radiographshowstypicalcysticlesions(arrows)inadditiontotrabecularlossin
the hand of a PLOSL patient. b) Coronal section of a control (left) and PLOSL (right)
hemispheres.Thereisaprofoundreductionofthedeepfrontalandtemporalwhitematter
(wm)inthePLOSLbrain.Notethesevereaffectionofthecingulategyrus(cg)andcorpus
















the Purkinje cells in the cerebellar cortex. At the brain stem and spinal cord levels























resorption capability of osteoclasts derived from peripheral blood mononuclear cells








patientswith homozygousmutations inDAP12 (PLOSLFin) andTREM2 (40G>T) and






































cells (c) efficiently form multinucleated
giant cells in 7 days (TRAP staining).
Note the numerous processes in
DAP12-deficientcells.
 47 





proliferate in a similar manner as the controls. Thus, the DAP12/TREM2 complex










after stimulation for 14 days the multinucleated DAP12-deficient osteoclastic cells
contained several small unorganized granular actin clusters. The TREM2-deficient
osteoclasticcellsgeneratedonlyonegranularring-likeactinclusterafter14days.The
transmembrane adaptor molecule DAP12 forms a complex with several different
activatingreceptorsdependingonthecell type(LanierandBakker2000). InDAP12-
deficientcells,allDAP12-associatedcellsurfacereceptorsarelikelytobeinactive.The
potential costimulatory function of other DAP12-associated cell surface receptors in





we analyzed the expression of cathepsin K, receptor activator of nuclear factor-κB
(RANK)(Nakagawaetal.1998),TRAP,andcalcitoninreceptor(CALCR)(Zaidietal.
2002)incellsstimulatedfor1,3,7,and21daysusingquantitativeRT-PCR.Cathepsin
K transcriptsbecamestronglyupregulatedafter stimulation for3days (p<0.001).No
difference between DAP12/TREM2-deficient and control cells was observed. The
transcript level of the gene encoding RANK, the receptor for RANKL, became
upregulated in bothgenetically deficient and control cells after stimulation for 1 day.
Therewasnosignificantdifferencebetweenthepatientandcontrolcells,althoughthe




DAP12- and TREM2-deficient cells expressed CALCR, the receptor regulating the
resorptionprocessofosteoclasts.Reliablequantitationcouldnotbeperformedduetoa
lowtranscript levelbutnoobviousdifferenceswereobservedbetweenthegenetically
deficient and control cells. Taken together, the delayed differentiation and impaired
resorptionfunctionofgeneticallydeficientosteoclastsisnotcausedbyalossofRANK,




The transcript level of DAP12 and TREM2 in normal cells followed each other and
increasedprogressivelyduring thestimulation forup to21days.A5-fold increase in











In order to assess the bone resorption capability of DAP12-deficient multinucleated
cells,weperformedaninvitroboneresorptionassay.WefirstinducedDAP12-deficient
andcontrolPBMCwithM-CSFandRANKLfor7daysandthentransferredthecellson
dentin slices for 7 days. Multinucleated DAP12-deficient cells stimulated for 7 days
before transferring on dentine slices were capable of bone resorption. Although the
samenumberofDAP12-deficientandcontrolcellswastransferredperdentinslice,the
totalsurfacearearesorbedbyDAP12-deficientosteoclastswasdramaticallyreduced,
being only 0.03% (a 3500-fold difference) of that of control osteoclasts (p<0.01).
Similarly, a striking 1000-fold difference in the average resorbed surface area per
multinucleated osteoclast between DAP12-deficient and control osteoclasts was
observed(36µm2and35700µm2,respectively,p<0.05).Remarkably,thesurfacearea
perresorptionpitgeneratedbyDAP12-deficientandcontrolosteoclastswasthesame.





type I collagen carboxy-terminal crosslinks (CTX), in serumofDAP12- andTREM2-
deficientpatients.CTXassayisconsideredasaspecificmethodtodeterminethebone
degradation rate in vivo (Rosenet al. 2000). TheaverageCTXconcentration in the
serum of the patients (mean age 36 years) was 40% higher than that of healthy























actin ring in the DAP12-deficient osteoclasts since the actin ring is known to be a
prerequisiteforefficientboneresorption(Saloetal.1997).Ontheotherhand,increased
CTXconcentrationsuggeststhat thecathepsinKmediatedboneresorptionrate,and
thereby theosteoclastic activity, is abnormally high in thepatients.This discrepancy
between in vitroand in vivo studiescouldbeexplainedby thepossibility that in the
course of time the genetically deficient osteoclasts finally differentiate into efficiently
resorbingosteoclasts.However,thestrikingdifferenceintheresorbedsurfaceareaper
cell between DAP12 -deficient and control osteoclasts may be artefactual to some
extentsincetheefficientresorptionbycontrolosteoclastscausesasignificantincrease
in extracellular calcium concentration that has been shown to induce apoptosis in
osteoclasts (Lorget et al. 2000). Therefore, the resorbed area per cell cannot be
accuratelydetermined.
Figure8.DAP12-deficientosteoclastsarecapableofboneresorption.(a)Controlosteoclasts
generated longcontinuous resorptionpits. (b)Theaveragesurfaceareaper resorptionpit






Inorder todetermine if thedifferentiationofDAP12-andTREM2-deficientosteoclast












In order to see whether the bone cells of PLOSL patients show features similar to
osteoclastic cells in vitro, we analyzed bone samples from two patients with




(Fig. 9).Unfortunately, bone samples frompatientswith TREM2mutations were not
available.However, it is likely that theosteoclasts inpatientswithTREM2mutations













Figure 9. Multinucleated bone-






In order to address the significance of Dap12 in mouse, we performed a detailed
histological and functional long-term follow-up analysis of the central nervous and















or obvious changes in bone mass. Further, there were no significant differences
between homozygous and heterozygous control mice in prepulse inhibition test that
























useful gene identification method since only little was known about the defective
biochemical pathways in PLOSL. The order in which the candidate genes were
analyzedwasdeterminedaccordingtotheknownorhypothesizedfunctioninadditionto




The candidate gene approach was successfully utilized in the identification of the
secondPLOSLgene,TREM2.SystematicalsequencingofallgenescodingforDAP12-
associatedproteinswouldhavebeenverytime-consumingandlaborious.Furthermore,
an advantage of this approach was that only a small amount of DNA was needed
because very little DNA was left from some individuals that were essential for the
analyses.Thesegregationanalysisofmarkerhaplotypesofthecandidategeneswas
performedintwoinformativeunrelatedfamilieswithatotalof4and7individualsandby
analyzing two or three markers per candidate locus. A complete co-segregation of
markerhaplotypesintheTREM2locusspannedalarge,approximately10cM,genomic
region. Identification of the second PLOSL gene is a good example of how the












extracellular domain followed by a 24 aa transmembrane segment and a 48 aa
cytoplasmic domain. The leader peptide and extracellular domains are encoded by
exons 1-2. Exons 3 and 4 code for the transmembrane as well as part of the
cytoplasmicdomains.OnthecellsurfaceDAP12 isexpressedasadisulphide-linked
 53 
homodimer mediated by two cysteine residues in the extracellular domain. The
transmembranedomainofDAP12containsanegativelychargedresiduethatmediates
theinteractionwithawidevarietyofassociatedreceptors,TREM2beingoneofthese.
This interaction ismediatedbyoppositelycharged amino-acids in the transmembrane









































complex. On the cell membrane (CM)
DAP12 is expressed as a homodimer
linked by cysteines in the extracellular
domainofDAP12.DAP12dimerislinked
toadimerofTREM2polypeptides.This
interaction is mediated by oppositely
charged amino acids in the
transmembrane domains of DAP12 (D)
and TREM2 (K). The interaction of
TREM2andanunidentifiedligandresults
inthephosphorylationoftheintracellullar
tyrosine-based activation domain (ITAM,
consensus sequence YxxL/Ix6-8YxxL/I,
where x denotes any amino acid) of
DAP12.PhosphorylatedITAMrecruitsthe
cytoplasmic protein tyrosine kinases
ZAP70andSYK.Thisinteractionleadsto
an increase in the intracellular Ca2+
concentration and subsequent cellular
activation. The stoichiometry between
DAP12andTREM2polypeptideshasnot
beenestablishedandisonlyhypothetical.





(75%) carry a mutation in DAP12, and 12 (25%) in TREM2. To date, six different
mutationshavebeenreportedinDAP12(I,II,unpublished,Kondoetal.2002),whereas





patients are homozygous for the same 5.3 kb deletion in DAP12 (PLOSLFin) (I).
MutationsinDAP12aretypicallyfoundinScandinaviaandJapan,whereasTREM2is
mutatedinothercountriesmorefrequentlythanDAP12.ItthusseemsthatTREM2 is










1-4 of the five exons ofDAP12 and result in a total loss ofDAP12 expression and






after52amino-acids.Themutationalsochanges theasparticacidresidue(D) in the
transmembrane domain, which is essential in mediating the interaction between the
DAP12andtheassociatedligand-bindingreceptors.Themissensemutation(145G>C)
inthePortuguesepatientresultsinconversionofGlysine49toArginineoneamino-acid



















Nine of ten of the identified mutations in TREM2 have occurred in the extracellular
ligand-binding domain (Fig. 12). The four nonsense mutations (40G>T /Glu14Stp,
C97>T /Gln33Stp, 132G>A /Trp44Stp, and 233G>A /Trp78Stp) result in a truncated
protein with no transmembrane domain. Two frameshift mutations due to single-
nucleotidedeletionintheextracellulardomainofTREM2(267delGand313delG)both




site in intron 3 (482+2T>C) is likely to result in skipping of exon 3 from themature










































































Mutations in genes coding for DAP12 –associated cell surface receptors other than
TREM2 have been reported only in NKG2C (Hikami et al. 2003). A large deletion
encompassingthewholeNKG2Cgeneisfoundin~5%oftheJapanesepopulation.The
deletiondoesnotappear tocauseanysymptoms.Mutations inZAP70encoding the
proteintyrosinekinase(PTK)ofthedownstreamsignaltransductionpathwayresultin
severe combined immunodeficiency (SCID) syndrome in humans. The function of T
cellsinSCIDpatientsisseverelyimpaired;thepatientslackperipheralCD8+Tcellsand







DAP12 belongs to a family of intracellular tyrosine-based activation motif (ITAM) -
bearingpolypeptides.SYKandZAP70playacrucialroleinthesignaltransductionof
hematopoietic cells (Chu et al. 1998). The cytoplasmic domain of the cell surface
receptorsutilizingSYKandZAP70donotusuallycontaintheITAMrequiredforbinding
these PTKs. Therefore, these receptors use transmembrane adaptor molecules as
intermediates (Lanier and Bakker 2000). All these adaptor molecules have small
extracellular regions that are not capable of interacting with ligands. The adaptors
typicallyhavecysteineresiduesintheextracellulardomainsandareexpressedonthe





IgGreceptor (CD16)and theTCRcomplexes(LanierandBakker2000).Mostof the
ITAM-bearing molecules contain multiple copies of ITAM (Love and Shores 2000)









DAP12-associated receptors transmit activating signals. Second, the cytoplasmic
domainofallthesereceptorslackstructuresrequiredfordownstreamsignaling.Third,
all receptors contain a positively charged amino acid residue in the transmembrane
domain,usually lysine (K+),or, insomecases,arginine (R+) that is required for the
associationwithDAP12.Severalofthesereceptorsbelongtoalargerfamilyincluding
both activating and inhibitory receptors. The inhibitory forms typically carry an
immunoreceptor tyrosine-based inhibitorymotif (ITIM) in the transmembranedomain.









other inhumanandmouse. In thenext section, theknownstructureand functionof
these genes and proteins are discussed.Most of the commonly used names of the
genes and proteins of theDAP12 signaling pathway are aliases and not the official




Triggering receptorsexpressedonmyeloidcells (TREM)are locatedonchr.6p21.1-
21.2.Like theotherDAP12-associatedreceptors in this locus(TREM2andNKp44),
TREM1carriesasingleV-typeIg-likeextracellulardomain.ThegenecodingforTREM1
consistsoffiveexonsthatcodefora234aapolypeptide.Gingrasandcolleagueshave
reported a splice variant of TREM1 that lacks the transmembrane domain. This
potentially represents a soluble variant of TREM1 (Gingras et al. 2002). TREM1 is
expressedonneutrophilsandmonocytesandmediatestheactivationof thesecells.













andTrem2b)geneshavebeen reported inmouse. These isoformsdiffer fromeach
otheronlybythreeaminoacids(sixbasepairs)scatteredthroughoutthepolypeptides,
and are therefore not alternatively spliced variants (Daws et al. 2001; Chung et al.
2002).Chung and colleagues have suggested the presence of twoTrem2 genes in
C57BL/6 andBALB/cmiceandone in 129, AJandDBAmice (Chung et al. 2002).
However,aligningofmouseTrem2bcDNAagainsttheavailableNCBImousegenome
sequencedatabasecoveringover96%ofthegenomicsequenceoftheC57BL/6strain,
in addition to sequences of the 129S1/SvlmJ, 129X1/SvL, DBA2/J and A/J2 mouse
strains (Celerawebpages) usingBLASTNalgorithm revealed only a single locus in
mouse chr. 17c, synthenic to human TREM2 in chr 6p21, and no evidence of the
presence of two Trem2 loci in C57BL/6 or other mouse strains. Therefore, different





















SIRPB1 (chr. 20p13) has been reported to be expressed in human monocytes and
dendriticcells(Dietrichetal.2000;Tomaselloetal.2000a).SIRPB1belongstoafamily
ofSIRPmolecules,andshowsahighhomologytoanITIM-containinginhibitoryreceptor




chr. 19q13.4) belongs to a multi-member family of killer cell immunoglobulin-like
receptors. This family contains both activating as well as ITIM-bearing inhibitory
receptors. KIR2DS2 is the only member in this family that associates with DAP12.
KIR2DS2triggersnaturalcytotoxicityinNKcells(Lanieretal.1998b).
NKp44
NKp44 (NCR2, LY95, Natural cytotoxicity triggering receptor 2; chr 6p21.1) is
specifically expressedon all restingandactivatedNKcells.NKp44 is located in the








total of 4.3%of the Japanesepopulationhasbeen reported to carry a homozygous





are thus inhibitory receptors. Activating members of this family that are known to








An interesting finding is that the clinical phenotype of patientswith eitherDAP12 or
TREM2 mutations is identical.  DAP12 transmits activating signals from several cell
surface receptors, and loss-of-function mutations in DAP12 potentially disrupt the
















awareofoneearlierexampleofan inheritedhumandiseaseresulting fromdefects in
differentcomponentsofthesamesignalingpathway.Autosomallydominantlyinherited
holoprosencephaly (HPE), in which the developing forebrain fails to divide into two
separate hemispheres and ventricles, is the most commonly occurring congenital
structural forebrain anomaly in humans. This nonsyndromic holoprosencephaly is
causedbymutationsingenesencodingthesignalingmolecule,SHH,anditsreceptor,
PTCH,inthesonichedgehogsignalingpathway.IncontrasttoPLOSL,thephenotypeof
holoprosencephaly isextremelyvariable, ranging fromalobarHPE(asingleventricle

















with a thalamus-accentuated reduction of myelin as early as 1.5 months of age,
whereastheDap12∆ex3-4miceweanalyzeddonotshowanysignsofmyelinlosseven
when aged 19 months. Furthermore, their Dap12∆ex1-3 mutant mice show behavioral
changes(abnormalsensorimotorgating)notseeninDap12∆ex3-4mice.Interestingly,the
Dap12∆ex1-3miceproducedbyKaifuandhiscolleaguespresentwithamildosteopetrosis
(pathological increase of bone mass), whereas the human PLOSL patients show
osteoporoticfeatures,theoppositeofosteopetrosis.

There are several potential explanations for the contradictory CNS manifestations
betweenDap12∆ex3-4  andDap12∆ex1-3.Onecould be thedifferent targetedmutations;
deletionofthetransmembranedomainandpartofthecytoplasmicdomainincludingthe
first tyrosine of the ITAM domain in Dap12∆ex3-4 mice, and deletion of the putative
promoteraswellastheextracellularandtransmembranedomainsinDap12∆ex1-3mouse
model. However, this seems unlikely because several studies have shown that the
transmembrane domain as well as the complete ITAM domain are required for the
complex formationofDap12with theassociatedreceptorsaswellas forcell-surface
transportationoftheDap12/receptorcomplex(Lanieretal.1998a;McVicaretal.1998;







and Dap12∆ex1-3 mouse strains represent outcomes of different knockout strategies:


















2000; Tomasello et al. 2000b). The immunological phenotype of the Dap12∆ex3-4
knockout mouse strain we used has been reported by Bakker and his colleagues
(Bakker et al. 2000). Interestingly, theseDap12∆ex3-4  knockoutmice are resistant to
experimental autoimmune encephalomyelitis (EAE), a mouse model for the human
disease multiple sclerosis (MS), induced by subcutaneous immunization with myelin






lacks the one tyrosine of the ITAM at position 75 (Y75) as well as the wild-type C
terminusaminoacids(Y75-R86)(Dap12K∆Y75)(Tomaselloetal.2000b).Tomaselloand
her colleagues have reported an accumulation of dendritic cells in muco-cutaneous
epithelia,associatedwithanimpairedhapten-specificcontactsensitivityinitiatedbyskin
dendritic cells. The NK cells of Dap12K∆Y75 mice show functional deficiency as
determinedbyanimpairedrecognitionandkillingofsomemousetumorcelllinesand




or 30 copies of human DAP12 genes both in myeloid and lymphoid compartments.
OverexpressionofDAP12hasbeenshowntoresult inTandBcell lymphopeniaand










mechanisms in PLOSL have evolved along with an increasing knowledge of the
disorder.Thefirsthypothesisconsideredanerrorinthesystemiclipidmetabolismtobe






mainpathogenicmechanism (Kalimoet al. 1994). In addition to thebrain, abnormal
bloodvesselshavealsobeenreportedinthebones,andimmunohistochemicalstudies
have shown extravasation of plasma constituents in the brain. The microvascular
alterationsobservedinthecerebralwhitematterofourpatientscouldconceivablylead















unpublished). Furthermore, our quantitativeRT-PCRanalyses show thatDAP12 and
TREM2areexpressed inPBMCdifferentiating toosteoclasts(IV). Itshouldbenoted
thatalthoughDAP12andTREM2areexpressedbymicroglialcells,theroleofmicroglia
intheCNSpathogenesisisunknown.Similarly,despitethecharacterizationofadefect




































are typically locatedat thedistal end of thebones. In addition to bone cavities, the
affected bones show pronounced focal osteoporotic features, i.e. marked loss of
































distal end of the bones remains unclear. Bones develop either by endochondral or
intramembranousossification.Inendochondralossificationacartilagemodelservesas
the precursor of bone, whereas intramembranous ossification occurs without an
interventionofacartilageprecursor(Rossetal.1995).Interestingly,allbonesaffected
by PLOSL are formed by endochondral ossification. No cystic lesions or pathologic
fractureshavebeenfoundinthebonesdevelopedbyintramembranousossification(the
skull, face, clavicle and mandible). However, this does not explain why the axial
skeleton (vertebrae), developed by endochondral ossification, is unaffected. The
pathogenicmechanismresultingintheaccumulationoflipidmaterialwithinthelesion
cavities remains unestablished. The accumulated lipid membranes may represent
incompletelyprocessedbreakdownproductsofcellmembranes.It isunlikelythatthe






The current literatureonPLOSLdescribes thebone lesionsas bone cysts or cystic
lesions.Thisisrathermisleadingsincethelesionsarenotrealcysts,thatbydefinition
havetobewell-demarcatedcavitieslinedbyepithelium(Dorland2000).Histologically,
the bone lesions in PLOSL are poorly demarcated cavities with inhomogeneous
contents.Thebonecavitiesresemblecystsonlyinradiographsofbones(Fig.6a,p.44).
It is actually possible that the cavities represent predilection regions of trabecular
osteoporosis-typebonelossthatisobservedaroundthecavities.

Figure 14. Contents of the bone
lesion.Thelesionsconsistofcavities
that radiologically resemble cysts.
Microscopically, the lesion cavities
contain convoluted lipid membrane
structures (C) filledwithamorphous
lipidsubstance,andfatcells(F).The
bone trabeculae (B) are partially
preserved. The scale bar




Certain forms of both inherited and sporadic dementia and other neurodegenerative
disorders are found to have several common neuropathological manifestations. For
example,thetwokeypathologicallesionsinAlzheimer'sdisease(AD)aretheplaques
(aggregatedβ-amyloid) and neurofibrillary tangles (intraneuronal aggregations of tau
protein).However,similarneurofibrillarytanglesarealsotheneuropathologicalhallmark
infrontotemporaldementiawithparkinsonismlinkedtochr.17(FTDP-17).Furthermore,
amyloid plaques may also occur in dementia with Lewy bodies as well as in




discussed above primarily affect the neurons. The neuropathology of PLOSL clearly
differs from the brain lesions found in the above-mentioned neurodegenerative
disorders.PLOSLdoesnotseemtobeaprimaryneurodegenerativedementiasincethe
neuropathological hallmark of PLOSL is the severe loss of myelin, and no signs of
intraneuronalorintraglialinclusionshavebeenidentified,despitetheballoonedcontours
found in some neurons.The presence of ballooned neuronsmight represent central




PLOSL patients show a prominent frontal lobe syndrome with loss of judgment,
euphoria, lack of social inhibitions (including moria, i.e. a tendency to joke), and
disturbanceofconcentration.Suchsymptomsindementingdisordersarecommon.The
frontallobesyndromeisatypicalmanifestationinseveralneurodegenerativedisorders,







The combination of frontal-type dementia, debuting in the fourth decade, and
radiologicallydemonstrablecyst-likeosseouslesionsisratheruniqueandmakesiteasy
to clinically distinguish PLOSL from the established forms of sporadic and familial
frontotemporaldementiasuchasPick’sdisease,nonspecificfrontallobedegeneration,
 67 
and the various entities of frontotemporal dementia and parkinsonism linked to
chromosome17(FTDP-17)(Fosteretal.1997),inseveralofwhichmutationsofthetau
gene have been reported (Hutton et al. 1998; Spillantini et al. 1998; Goedert et al.
1999). At the tissue level, there is no beta-amyloid accumulation, and the various
synucleinopathiesandtauopathies(HardyandGwinn-Hardy1998)canbeexcludedby
the absence of intraneuronal or glial deposits, immunoreactive for α-synuclein,
phosphorylated tau, or ubiquitin (Dickson 1999). A lack of immunoreactivity for




cavities are not found in the known forms of adult-onset leukodystrophy. The white
matter lesions in PLOSL are associated with vascular alterations, distinct from the
various cerebral amyloid angiopathies and cerebral autosomal dominant arteriopathy
withsubcorticalinfarctsandleukoencephalopathy(CADASIL)(Kalimoetal.1999)bythe
lackof congophiliaor granularbasophilicandPAS-positivematerial in the thickened



























lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL,Nasu-
Hakoladisease),amonogenicmodelfordementiaandbonedegeneration.Inthefirst
original publication the causativegene forPLOSLwas identifiedasDAP12, and the
mutationsresponsibleforthediseaseinmajorityofthepatientswereestablished.Inthe
second article the molecular genetic background of PLOSL was completed by the
identificationofmutationsinthesecondPLOSLgenecodingfortheDAP12-associated
receptorTREM2.ThethirdarticlecharacterizedthenaturalcourseofPLOSLinrespect
to the clinical, radiological, histopathological, and electrophysiological manifestations.
The fourth original article characterized the role of DAP12/TREM2 signaling in














molecular mechanisms of disorders of the brain. I hope that this study willl provide
perspectives for the studies of other degenerative disorders of the central nervous
systemandbonesuchasmorecommonformsofdementiaandosteoporosis.Finally,I
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